Diaz M, Quesada-Lopez T, Villarroya F, Casano P, Lopez-Bermejo A, de Zegher F
Int J Mol Sci. 2025; 26(4).
PMID: 40004184
PMC: 11854951.
DOI: 10.3390/ijms26041721.
Kagan T, Gabay M, Meenakshisundaram A, Levi Y, Eid S, Malchenko N
Nat Methods. 2025; .
PMID: 39979596
DOI: 10.1038/s41592-025-02610-9.
Molinaro A, Mazzoli A, Gaudi A, Chand Gupta A, Rodrigues Silva V, Ramel D
iScience. 2025; 28(1):111562.
PMID: 39811649
PMC: 11732162.
DOI: 10.1016/j.isci.2024.111562.
Wan X, Zhang Y, Zhang K, Mou Y, Jin X, Huang X
Adv Ophthalmol Pract Res. 2025; 5(1):1-12.
PMID: 39758836
PMC: 11699629.
DOI: 10.1016/j.aopr.2024.08.003.
Endicott S
Front Aging. 2024; 5:1509400.
PMID: 39687864
PMC: 11647017.
DOI: 10.3389/fragi.2024.1509400.
Transcranial direct current stimulation enhances the protective effect of isoflurane preconditioning on cerebral ischemia/reperfusion injury: A new mechanism associated with the nuclear protein Akirin2.
Kong X, Lyu W, Lin X, Feng H, Xu L, Li C
CNS Neurosci Ther. 2024; 30(9):e70033.
PMID: 39267282
PMC: 11393012.
DOI: 10.1111/cns.70033.
The role of brown adipose tissue in mediating healthful longevity.
Zhang J, Kibret B, Vatner D, Vatner S
J Cardiovasc Aging. 2024; 4(2).
PMID: 39119146
PMC: 11309368.
DOI: 10.20517/jca.2024.01.
Genomic Deletion of PFKFB3 Decreases In Vivo Tumorigenesis.
Imbert-Fernandez Y, Chang S, Lanceta L, Sanders N, Chesney J, Clem B
Cancers (Basel). 2024; 16(13).
PMID: 39001392
PMC: 11240529.
DOI: 10.3390/cancers16132330.
Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms.
Chang C, Chavarro V, Gerstl J, Blitz S, Spanehl L, Dubinski D
Int J Mol Sci. 2024; 25(12).
PMID: 38928445
PMC: 11203521.
DOI: 10.3390/ijms25126733.
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of -null, melanoma to BRAF/MEK inhibition.
DuBose E, Bevill S, Mitchell D, Sciaky N, Golitz B, Dixon S
Front Oncol. 2024; 14:1191217.
PMID: 38854737
PMC: 11159048.
DOI: 10.3389/fonc.2024.1191217.
Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology.
Hu D, Zhang Z, Liu X, Wu Y, An Y, Wang W
J Transl Med. 2024; 22(1):512.
PMID: 38807223
PMC: 11134716.
DOI: 10.1186/s12967-024-05326-0.
Critical roles and clinical perspectives of RNA methylation in cancer.
Li G, Yao Q, Liu P, Zhang H, Liu Y, Li S
MedComm (2020). 2024; 5(5):e559.
PMID: 38721006
PMC: 11077291.
DOI: 10.1002/mco2.559.
Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism.
Morozumi K, Kawasaki Y, Sato T, Maekawa M, Takasaki S, Shimada S
Metabolites. 2024; 14(3).
PMID: 38535330
PMC: 10971907.
DOI: 10.3390/metabo14030170.
Glioblastoma stem cell-derived exosomal miR-374b-3p promotes tumor angiogenesis and progression through inducing M2 macrophages polarization.
Huang S, Zhang P, Yin N, Xu Z, Liu X, Wu A
iScience. 2024; 27(3):109270.
PMID: 38487014
PMC: 10937837.
DOI: 10.1016/j.isci.2024.109270.
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.
Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J
Acta Pharm Sin B. 2024; 14(3):953-1008.
PMID: 38487001
PMC: 10935242.
DOI: 10.1016/j.apsb.2023.12.003.
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle.
Wang B, Pei J, Xu S, Liu J, Yu J
J Exp Clin Cancer Res. 2024; 43(1):74.
PMID: 38459595
PMC: 10921613.
DOI: 10.1186/s13046-024-02994-0.
Recapitulation of anti-aging phenotypes by global overexpression of PTEN in mice.
Hager M, Chang P, Lee M, Burns C, Endicott S, Miller R
Geroscience. 2023; 46(2):2653-2670.
PMID: 38114855
PMC: 10828233.
DOI: 10.1007/s11357-023-01025-8.
Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
Nguele Meke F, Bai Y, Ruiz-Avila D, Carlock C, Ayub J, Miao J
Cancer Res Commun. 2023; 4(1):5-17.
PMID: 38047587
PMC: 10764713.
DOI: 10.1158/2767-9764.CRC-23-0308.
Epigenetic regulation in lung cancer.
Ramazi S, Dadzadi M, Daddzadi M, Sahafnejad Z, Allahverdi A
MedComm (2020). 2023; 4(6):e401.
PMID: 37901797
PMC: 10600507.
DOI: 10.1002/mco2.401.
Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers.
Kaysudu I, Gungul T, Atici S, Yilmaz S, Bayram E, Guven G
Cancer Sci. 2023; 114(11):4365-4375.
PMID: 37706278
PMC: 10637061.
DOI: 10.1111/cas.15960.